In the latest session, Lexaria Bioscience Corp (NASDAQ: LEXX) closed at $4.18 down -33.12% from its previous closing price of $6.25. In other words, the price has decreased by -$2.0700 from its previous closing price. On the day, 3624375 shares were traded.
Ratios:
For a deeper understanding of Lexaria Bioscience Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.63 and its Current Ratio is at 21.63. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEXX now has a Market Capitalization of 51.61M and an Enterprise Value of 49.74M. For the stock, the TTM Price-to-Sale (P/S) ratio is 150.11 while its Price-to-Book (P/B) ratio in mrq is 11.52. Its current Enterprise Value per Revenue stands at 177.81 whereas that against EBITDA is -8.53.
Stock Price History:
Over the past 52 weeks, LEXX has reached a high of $6.85, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 2.2289, while the 200-Day Moving Average is calculated to be 1.3380.
Shares Statistics:
For the past three months, LEXX has traded an average of 325.58K shares per day and 1.45M over the past ten days. A total of 12.21M shares are outstanding, with a floating share count of 10.64M. Insiders hold about 12.84% of the company’s shares, while institutions hold 9.83% stake in the company. Shares short for LEXX as of Feb 29, 2024 were 667.91k with a Short Ratio of 2.05, compared to 592.77k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.40% and a Short% of Float of 5.68%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.1, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.13 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.47 and -$0.6 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.49, with 2 analysts recommending between -$0.48 and -$0.51.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for LEXX’s current fiscal year. The highest revenue estimate was $810k, while the lowest revenue estimate was $150k, resulting in an average revenue estimate of $480k. In the same quarter a year ago, actual revenue was $226k, up 112.40% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $970k in the next fiscal year. The high estimate is $970k and the low estimate is $970k. The average revenue growth estimate for next year is up 102.10% from the average revenue estimate for this year.
